{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T19:58:46Z","timestamp":1779134326141,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T00:00:00Z","timestamp":1539302400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["RG 5112A5\/2"],"award-info":[{"award-number":["RG 5112A5\/2"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Henry Ford Hospital","award":["A20040 and A20020"],"award-info":[{"award-number":["A20040 and A20020"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroimmune Pharmacol"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s11481-018-9815-4","type":"journal-article","created":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T03:13:27Z","timestamp":1539314007000},"page":"241-250","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Urinary and Plasma Metabolomics Identify the Distinct Metabolic Profile of Disease State in Chronic Mouse Model of Multiple Sclerosis"],"prefix":"10.1007","volume":"14","author":[{"given":"J.","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Cerghet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. M.","family":"Poisson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Datta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Labuzek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Suhail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Rattan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7123-829X","authenticated-orcid":false,"given":"Shailendra","family":"Giri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,12]]},"reference":[{"key":"9815_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/08820138209050718","volume":"11","author":"SL Abreu","year":"1982","unstructured":"Abreu SL (1982) Suppression of experimental allergic encephalomyelitis by interferon. Immunol Commun 11:1\u20137","journal-title":"Immunol Commun"},{"key":"9815_CR2","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/bib\/bbl022","volume":"7","author":"T Aittokallio","year":"2006","unstructured":"Aittokallio T, Schwikowski B (2006) Graph-based methods for analysing networks in cell biology. Brief Bioinform 7:243\u2013255","journal-title":"Brief Bioinform"},{"key":"9815_CR3","doi-asserted-by":"crossref","unstructured":"Bhargava P, Fitzgerald KC, Calabresi PA, Mowry EM (2017) Metabolic alterations in multiple sclerosis and the impact of vitamin D supplementation. JCI Insight 2","DOI":"10.1172\/jci.insight.95302"},{"key":"9815_CR4","doi-asserted-by":"crossref","unstructured":"Birkner K, Wasser B, Loos J, Plotnikov A, Seger R, Zipp F, Witsch E, Bittner S (2017) The role of ERK signaling in experimental autoimmune encephalomyelitis. Int J Mol Sci 18","DOI":"10.3390\/ijms18091990"},{"key":"9815_CR5","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1002\/jnr.24224","volume":"96","author":"I Bjelobaba","year":"2018","unstructured":"Bjelobaba I, Begovic-Kupresanin V, Pekovic S, Lavrnja I (2018) Animal models of multiple sclerosis: focus on experimental autoimmune encephalomyelitis. J Neurosci Res 96:1021\u20131042","journal-title":"J Neurosci Res"},{"key":"9815_CR6","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/ana.410320205","volume":"32","author":"H Bruhn","year":"1992","unstructured":"Bruhn H, Frahm J, Merboldt KD, Hanicke W, Hanefeld F, Christen HJ, Kruse B, Bauer HJ (1992) Multiple sclerosis in children: cerebral metabolic alterations monitored by localized proton magnetic resonance spectroscopy in vivo. Ann Neurol 32:140\u2013150","journal-title":"Ann Neurol"},{"key":"9815_CR7","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1007\/s00330-017-5064-9","volume":"28","author":"G Cao","year":"2018","unstructured":"Cao G, Edden RAE, Gao F, Li H, Gong T, Chen W, Liu X, Wang G, Zhao B (2018) Reduced GABA levels correlate with cognitive impairment in patients with relapsing-remitting multiple sclerosis. Eur Radiol 28:1140\u20131148","journal-title":"Eur Radiol"},{"key":"9815_CR8","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1093\/brain\/awv209","volume":"138","author":"N Cawley","year":"2015","unstructured":"Cawley N, Solanky BS, Muhlert N, Tur C, Edden RA, Wheeler-Kingshott CA, Miller DH, Thompson AJ, Ciccarelli O (2015) Reduced gamma-aminobutyric acid concentration is associated with physical disability in progressive multiple sclerosis. Brain J Neurol 138:2584\u20132595","journal-title":"Brain J Neurol"},{"key":"9815_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.abb.2010.12.017","volume":"508","author":"SC Daubner","year":"2011","unstructured":"Daubner SC, Le T, Wang S (2011) Tyrosine hydroxylase and regulation of dopamine synthesis. Arch Biochem Biophys 508:1\u201312","journal-title":"Arch Biochem Biophys"},{"key":"9815_CR10","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1212\/WNL.0000000000000905","volume":"83","author":"AM Dickens","year":"2014","unstructured":"Dickens AM, Larkin JR, Griffin JL, Cavey A, Matthews L, Turner MR, Wilcock GK, Davis BG, Claridge TD, Palace J, Anthony DC, Sibson NR (2014) A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis. Neurology 83:1492\u20131499","journal-title":"Neurology"},{"key":"9815_CR11","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1039\/B906712B","volume":"40","author":"WB Dunn","year":"2011","unstructured":"Dunn WB, Broadhurst DI, Atherton HJ, Goodacre R, Griffin JL (2011) Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy. Chem Soc Rev 40:387\u2013426","journal-title":"Chem Soc Rev"},{"key":"9815_CR12","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1021\/cb300673e","volume":"8","author":"T Gebregiworgis","year":"2013","unstructured":"Gebregiworgis T, Massilamany C, Gangaplara A, Thulasingam S, Kolli V, Werth MT, Dodds ED, Steffen D, Reddy J, Powers R (2013) Potential of urinary metabolites for diagnosing multiple sclerosis. ACS Chem Biol 8:684\u2013690","journal-title":"ACS Chem Biol"},{"key":"9815_CR13","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.mehy.2008.04.026","volume":"71","author":"X Gong","year":"2008","unstructured":"Gong X, Xie Z, Zuo H (2008) A new track for understanding the pathogenesis of multiple sclerosis: from the perspective of early developmental deficit caused by the potential 5-HT deficiency in individuals in high-latitude areas. Med Hypotheses 71:580\u2013583","journal-title":"Med Hypotheses"},{"key":"9815_CR14","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1212\/WNL.45.7.1268","volume":"45","author":"KP Johnson","year":"1995","unstructured":"Johnson KP, Brooks BR, Cohen JA, Ford CC, Goldstein J, Lisak RP, Myers LW, Panitch HS, Rose JW, Schiffer RB (1995) Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The copolymer 1 multiple sclerosis study group. Neurology 45:1268\u20131276","journal-title":"Neurology"},{"key":"9815_CR15","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.1128\/MCB.00688-13","volume":"33","author":"DN Krementsov","year":"2013","unstructured":"Krementsov DN, Thornton TM, Teuscher C, Rincon M (2013) The emerging role of p38 mitogen-activated protein kinase in multiple sclerosis and its models. Mol Cell Biol 33:3728\u20133734","journal-title":"Mol Cell Biol"},{"key":"9815_CR16","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S0035-3787(07)90474-9","volume":"163","author":"H Lassmann","year":"2007","unstructured":"Lassmann H (2007) Experimental models of multiple sclerosis. Rev Neurol 163:651\u2013655","journal-title":"Rev Neurol"},{"key":"9815_CR17","doi-asserted-by":"publisher","first-page":"41473","DOI":"10.1038\/srep41473","volume":"7","author":"CK Lim","year":"2017","unstructured":"Lim CK, Bilgin A, Lovejoy DB, Tan V, Bustamante S, Taylor BV, Bessede A, Brew BJ, Guillemin GJ (2017) Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression. Sci Rep 7:41473","journal-title":"Sci Rep"},{"key":"9815_CR18","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/S0306-9877(02)00261-X","volume":"59","author":"C Loder","year":"2002","unstructured":"Loder C, Allawi J, Horrobin DF (2002) Treatment of multiple sclerosis with lofepramine, L-phenylalanine and vitamin B(12): mechanism of action and clinical importance: roles of the locus coeruleus and central noradrenergic systems. Med Hypotheses 59:594\u2013602","journal-title":"Med Hypotheses"},{"key":"9815_CR19","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jneuroim.2016.08.013","volume":"304","author":"AE Lovett-Racke","year":"2017","unstructured":"Lovett-Racke AE (2017) Contribution of EAE to understanding and treating multiple sclerosis. J Neuroimmunol 304:40\u201342","journal-title":"J Neuroimmunol"},{"key":"9815_CR20","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.bbrc.2006.12.169","volume":"354","author":"NW Lutz","year":"2007","unstructured":"Lutz NW, Viola A, Malikova I, Confort-Gouny S, Ranjeva JP, Pelletier J, Cozzone PJ (2007a) A branched-chain organic acid linked to multiple sclerosis: first identification by NMR spectroscopy of CSF. Biochem Biophys Res Commun 354:160\u2013164","journal-title":"Biochem Biophys Res Commun"},{"key":"9815_CR21","doi-asserted-by":"publisher","first-page":"e595","DOI":"10.1371\/journal.pone.0000595","volume":"2","author":"NW Lutz","year":"2007","unstructured":"Lutz NW, Viola A, Malikova I, Confort-Gouny S, Audoin B, Ranjeva JP, Pelletier J, Cozzone PJ (2007b) Inflammatory multiple-sclerosis plaques generate characteristic metabolic profiles in cerebrospinal fluid. PLoS One 2:e595","journal-title":"PLoS One"},{"key":"9815_CR22","unstructured":"Mangalam A, Poisson L, Nemutlu E, Datta I, Denic A, Dzeja P, Rodriguez M, Rattan R, Giri S (2013) Profile of circulatory metabolites in a relapsing-remitting animal model of multiple sclerosis using global metabolomics. J Clin Cell Immunol 4"},{"key":"9815_CR23","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.molmed.2013.08.001","volume":"19","author":"C Mc Guire","year":"2013","unstructured":"Mc Guire C, Prinz M, Beyaert R, van Loo G (2013) Nuclear factor kappa B (NF-kappaB) in multiple sclerosis pathology. Trends Mol Med 19:604\u2013613","journal-title":"Trends Mol Med"},{"key":"9815_CR24","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jns.2011.11.003","volume":"314","author":"L Melamud","year":"2012","unstructured":"Melamud L, Golan D, Luboshitzky R, Lavi I, Miller A (2012) Melatonin dysregulation, sleep disturbances and fatigue in multiple sclerosis. J Neurol Sci 314:37\u201340","journal-title":"J Neurol Sci"},{"key":"9815_CR25","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.pneurobio.2010.06.005","volume":"92","author":"E Mix","year":"2010","unstructured":"Mix E, Meyer-Rienecker H, Hartung HP, Zettl UK (2010) Animal models of multiple sclerosis--potentials and limitations. Prog Neurobiol 92:386\u2013404","journal-title":"Prog Neurobiol"},{"key":"9815_CR26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.bbrc.2009.05.106","volume":"386","author":"N Nath","year":"2009","unstructured":"Nath N, Khan M, Rattan R, Mangalam A, Makkar RS, de Meester C, Bertrand L, Singh I, Chen Y, Viollet B, Giri S (2009) Loss of AMPK exacerbates experimental autoimmune encephalomyelitis disease severity. Biochem Biophys Res Commun 386:16\u201320","journal-title":"Biochem Biophys Res Commun"},{"key":"9815_CR27","doi-asserted-by":"publisher","first-page":"e1720","DOI":"10.1038\/cddis.2015.93","volume":"6","author":"T Noro","year":"2015","unstructured":"Noro T, Namekata K, Kimura A, Guo X, Azuchi Y, Harada C, Nakano T, Tsuneoka H, Harada T (2015) Spermidine promotes retinal ganglion cell survival and optic nerve regeneration in adult mice following optic nerve injury. Cell Death Dis 6:e1720","journal-title":"Cell Death Dis"},{"key":"9815_CR28","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1212\/WNL.43.4.662","volume":"43","author":"DW Paty","year":"1993","unstructured":"Paty DW, Li DK (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS\/MRI study group and the IFNB multiple sclerosis study group. Neurology 43:662\u2013667","journal-title":"Neurology"},{"key":"9815_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13048-015-0140-8","volume":"8","author":"LM Poisson","year":"2015","unstructured":"Poisson LM, Munkarah A, Madi H, Datta I, Hensley-Alford S, Tebbe C, Buekers T, Giri S, Rattan R (2015a) A metabolomic approach to identifying platinum resistance in ovarian cancer. J Ovarian Res 8:13","journal-title":"J Ovarian Res"},{"key":"9815_CR30","doi-asserted-by":"publisher","first-page":"30697","DOI":"10.1074\/jbc.M115.679068","volume":"290","author":"LM Poisson","year":"2015","unstructured":"Poisson LM, Suhail H, Singh J, Datta I, Denic A, Labuzek K, Hoda MN, Shankar A, Kumar A, Cerghet M, Elias S, Mohney RP, Rodriguez M, Rattan R, Mangalam AK, Giri S (2015b) Untargeted plasma metabolomics identifies endogenous metabolite with drug-like properties in chronic animal model of multiple sclerosis. J Biol Chem 290:30697\u201330712","journal-title":"J Biol Chem"},{"key":"9815_CR31","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/brain\/awq362","volume":"134","author":"PE Polak","year":"2011","unstructured":"Polak PE, Kalinin S, Feinstein DL (2011) Locus coeruleus damage and noradrenaline reductions in multiple sclerosis and experimental autoimmune encephalomyelitis. Brain J Neurol 134:665\u2013677","journal-title":"Brain J Neurol"},{"key":"9815_CR32","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1056\/NEJMoa044397","volume":"354","author":"CH Polman","year":"2006","unstructured":"Polman CH, O'Connor PW, Havrdova E, Hutchinson M, Kappos L, Miller DH, Phillips JT, Lublin FD, Giovannoni G, Wajgt A, Toal M, Lynn F, Panzara MA, Sandrock AW, Investigators A (2006) A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 354:899\u2013910","journal-title":"N Engl J Med"},{"key":"9815_CR33","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1177\/1352458513516528","volume":"20","author":"SN Reinke","year":"2014","unstructured":"Reinke SN, Broadhurst DL, Sykes BD, Baker GB, Catz I, Warren KG, Power C (2014) Metabolomic profiling in multiple sclerosis: insights into biomarkers and pathogenesis. Mult Scler 20:1396\u20131400","journal-title":"Mult Scler"},{"key":"9815_CR34","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3109\/00207459608986697","volume":"86","author":"R Sandyk","year":"1996","unstructured":"Sandyk R (1996) Tryptophan availability and the susceptibility to stress in multiple sclerosis: a hypothesis. Int J Neurosci 86:47\u201353","journal-title":"Int J Neurosci"},{"key":"9815_CR35","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/j.1600-0404.1985.tb00879.x","volume":"72","author":"G Steen","year":"1985","unstructured":"Steen G, Axelsson H, Bowallius M, Holthuis N, Molander BM (1985) Isoprenoid biosynthesis in multiple sclerosis. Acta Neurol Scand 72:328\u2013335","journal-title":"Acta Neurol Scand"},{"key":"9815_CR36","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/0006-3002(62)90357-8","volume":"63","author":"K Sumizu","year":"1962","unstructured":"Sumizu K (1962) Oxidation of hypotaurine in rat liver. Biochim Biophys Acta 63:210\u2013212","journal-title":"Biochim Biophys Acta"},{"key":"9815_CR37","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/eji.1830010406","volume":"1","author":"D Teitelbaum","year":"1971","unstructured":"Teitelbaum D, Meshorer A, Hirshfeld T, Arnon R, Sela M (1971) Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide. Eur J Immunol 1:242\u2013248","journal-title":"Eur J Immunol"},{"key":"9815_CR38","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/978-1-4899-0182-8_41","volume":"403","author":"A Tsuji","year":"1996","unstructured":"Tsuji A, Tamai I (1996) Sodium- and chloride-dependent transport of taurine at the blood-brain barrier. Adv Exp Med Biol 403:385\u2013391","journal-title":"Adv Exp Med Biol"},{"key":"9815_CR39","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1111\/j.1471-4159.1974.tb04309.x","volume":"22","author":"N Urquhart","year":"1974","unstructured":"Urquhart N, Perry TL, Hansen S, Kennedy J (1974) Passage of taurine into adult mammalian brain. J Neurochem 22:871\u2013872","journal-title":"J Neurochem"},{"key":"9815_CR40","doi-asserted-by":"publisher","first-page":"e321","DOI":"10.1212\/NXI.0000000000000321","volume":"4","author":"P Villoslada","year":"2017","unstructured":"Villoslada P, Alonso C, Agirrezabal I, Kotelnikova E, Zubizarreta I, Pulido-Valdeolivas I, Saiz A, Comabella M, Montalban X, Villar L, Alvarez-Cermeno JC, Fernandez O, Alvarez-Lafuente R, Arroyo R, Castro A (2017) Metabolomic signatures associated with disease severity in multiple sclerosis. Neurol Neuroimmunol Neuroinflamm 4:e321","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"9815_CR41","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1136\/jnnp.73.3.246","volume":"73","author":"DT Wade","year":"2002","unstructured":"Wade DT, Young CA, Chaudhuri KR, Davidson DL (2002) A randomised placebo controlled exploratory study of vitamin B-12, lofepramine, and L-phenylalanine (the \"Cari Loder regime\") in the treatment of multiple sclerosis. J Neurol Neurosurg Psychiatry 73:246\u2013249","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9815_CR42","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/npp.2013.167","volume":"39","author":"PL Wood","year":"2014","unstructured":"Wood PL (2014) Mass spectrometry strategies for clinical metabolomics and lipidomics in psychiatry, neurology, and neuro-oncology. Neuropsychopharmacology 39:24\u201333","journal-title":"Neuropsychopharmacology"},{"key":"9815_CR43","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1038\/cdd.2016.71","volume":"23","author":"Q Yang","year":"2016","unstructured":"Yang Q, Zheng C, Cao J, Cao G, Shou P, Lin L, Velletri T, Jiang M, Chen Q, Han Y, Li F, Wang Y, Cao W, Shi Y (2016) Spermidine alleviates experimental autoimmune encephalomyelitis through inducing inhibitory macrophages. Cell Death Differ 23:1850\u20131861","journal-title":"Cell Death Differ"},{"key":"9815_CR44","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/356063a0","volume":"356","author":"TA Yednock","year":"1992","unstructured":"Yednock TA, Cannon C, Fritz LC, Sanchez-Madrid F, Steinman L, Karin N (1992) Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature 356:63\u201366","journal-title":"Nature"}],"container-title":["Journal of Neuroimmune Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-018-9815-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11481-018-9815-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-018-9815-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T19:25:03Z","timestamp":1570821903000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11481-018-9815-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,12]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["9815"],"URL":"https:\/\/doi.org\/10.1007\/s11481-018-9815-4","relation":{},"ISSN":["1557-1890","1557-1904"],"issn-type":[{"value":"1557-1890","type":"print"},{"value":"1557-1904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,12]]},"assertion":[{"value":"11 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}